Gomaa Mostafa‐Hedeab
- Molecular Medicine top 5%
- Pharmacology top 5%
- Drug-Induced Hepatotoxicity and Protection 5
- Biochemistry top 10%
- Neurology top 10%
-
- Natural Antidiabetic Agents Studies 9
- Diet, Metabolism, and Disease 4
-
- Computational Drug Discovery Methods 8
-
- COVID-19 Clinical Research Studies 5
-
- Liver Disease Diagnosis and Treatment 5
-
- Liver Disease and Transplantation 4
-
- Nanoparticles: synthesis and applications 4
- Co-authors
- Gaber El‐Saber BatihaAmany Abdel-Rahman MohamedHayder M. Al‐kuraishyAli I. Al‐GareebCarlos Adam Conte‐JúniorTalha Bin EmranAyman M. MahmoudEman S. El‐Shetry
- Partner nations
- EgyptSaudi ArabiaNigeria
In The Last Decade
Gomaa Mostafa‐Hedeab
67 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 120
- Molecular Medicine 79
- Pharmacology 133
- Complementary and alternative medicine 120
- Biochemistry 68
- Neurology 66
Countries citing papers authored by Gomaa Mostafa‐Hedeab
This map shows the geographic impact of Gomaa Mostafa‐Hedeab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gomaa Mostafa‐Hedeab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gomaa Mostafa‐Hedeab more than expected).
Fields of papers citing papers by Gomaa Mostafa‐Hedeab
This network shows the impact of papers produced by Gomaa Mostafa‐Hedeab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gomaa Mostafa‐Hedeab. The network helps show where Gomaa Mostafa‐Hedeab may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gomaa Mostafa‐Hedeab, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | 2023 | 26 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 26 | |
| 5 | 2022 | 13 | |
| 6 | 2022 | 96 | |
| 7 | 2022 | 3 | |
| 8 | 2022 | 24 | |
| 9 | 2022 | 52 | |
| 10 | 2022 | 3 | |
| 11 | 2022 | 13 | |
| 12 | 2022 | 49 | |
| 13 | 2022 | 12 | |
| 14 | 2022 | 21 | |
| 15 | 2021 | 35 | |
| 16 | 2021 | 21 | |
| 17 | 2021 | 50 | |
| 18 | 2021 | 27 | |
| 19 | 2020 | 3 | |
| 20 | 2017 | 53 |
About Gomaa Mostafa‐Hedeab
Gomaa Mostafa‐Hedeab is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Endocrinology, Diabetes and Metabolism, having authored 68 papers that have together received 1.3k indexed citations. Recurring topics across this work include Natural Antidiabetic Agents Studies (9 papers), Computational Drug Discovery Methods (8 papers), Drug-Induced Hepatotoxicity and Protection (5 papers), COVID-19 Clinical Research Studies (5 papers), Liver Disease Diagnosis and Treatment (5 papers), Diet, Metabolism, and Disease (4 papers), Liver Disease and Transplantation (4 papers) and Nanoparticles: synthesis and applications (4 papers). The work is most often cited by research in Molecular Medicine (79 citations), Pharmacology (133 citations) and Complementary and alternative medicine (120 citations). Gomaa Mostafa‐Hedeab has collaborated with scholars based in Egypt, Saudi Arabia and Nigeria. Frequent co-authors include Gaber El‐Saber Batiha, Amany Abdel-Rahman Mohamed, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Carlos Adam Conte‐Júnior, Talha Bin Emran, Ayman M. Mahmoud, Eman S. El‐Shetry, Amr R. Zaki and Mohamed M.M. Metwally. Their work appears in journals such as Scientific Reports, Frontiers in Immunology and Molecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.